Statin Comparative Studies Needed, Oregon Drug Effectiveness Review Project Suggests
This article was originally published in The Pink Sheet Daily
DERP wants comparative-effectiveness study on LDL-c lowering capabilities and adverse events.
You may also be interested in...
PBM will feature link to Consumer Reports Best Buy Drugs for certain medication classes.
Crestor sales grew 47% in the second quarter; entry of generic simvastatin caused some expected “disruption” in the marketplace.
When total healthcare costs are considered, atorvastatin is more cost-effective than simvastatin even when Zocor is discounted 50% from its current price, Pfizer analysis says.